Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 717198, 4 pages
http://dx.doi.org/10.1155/2014/717198
Research Article

Interpreting the Consequences of Metformin Accumulation in an Emergency Context: Impact of the Time Frame on the Blood Metformin Levels

1Service d’Endocrinologie-Nutrition, Hôpital Sud, 80054 Amiens, France
2INSERM U-1088, Université de Picardie Jules Verne, 80037 Amiens, France

Received 7 October 2014; Accepted 22 November 2014; Published 17 December 2014

Academic Editor: Mario Maggi

Copyright © 2014 Jean-Daniel Lalau and Farshad Kajbaf. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Prikis, E. L. Mesler, V. L. Hood, and W. J. Weise, “When a friend can become an enemy! Recognition and management of metformin-associated lactic acidosis,” Kidney International, vol. 72, no. 9, pp. 1157–1160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Peters, N. Jay, D. Barraud et al., “Metformin-associated lactic acidosis in an intensive care unit,” Critical Care, vol. 12, no. 6, article R149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-D. Lalau, P. Arnouts, A. Sharif, and M. E. de Broe, “Metformin and other antidiabetic agents in renal failure patients,” Kidney International, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Gionfriddo, O. L. Morey-Vargas, J. P. Brito, A. L. Leppin, M. H. Murad, and V. M. Montori, “Systematic reviews to ascertain the safety of diabetes medications topical collection on pharmacologic treatment of type 2 diabetes,” Current Diabetes Reports, vol. 14, article 478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Christensen, C. Brasch-Andersen, H. Green et al., “The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c,” Pharmacogenetics and Genomics, vol. 21, no. 12, pp. 837–850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Robert, S. Fendri, L. Hary, C. Lacroix, M. Andréjak, and J. D. Lalau, “Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects,” Diabetes and Metabolism, vol. 29, no. 3, pp. 279–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-D. Lalau, A.-S. Lemaire-Hurtel, and C. Lacroix, “Establishment of a database of metformin plasma concentrations and erythrocyte levels in normal and emergency situations,” Clinical Drug Investigation, vol. 31, no. 6, pp. 435–438, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Luft, G. Deichsel, R. M. Schmulling, W. Stein, and M. Eggstein, “Definition of clinically relevant lactic acidosis in patients with internal diseases,” The American Journal of Clinical Pathology, vol. 80, no. 4, pp. 484–489, 1983. View at Google Scholar · View at Scopus
  9. J.-D. Lalau and C. Lacroix, “Measurement of metformin concentration in erythrocytes: Clinical implications,” Diabetes, Obesity and Metabolism, vol. 5, no. 2, pp. 92–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Vecchio and A. Protti, “Metformin-induced lactic acidosis: no one left behind,” Critical Care, vol. 15, article 107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. A. Mizock and J. L. Falk, “Lactic acidosis in critical illness,” Critical Care Medicine, vol. 20, no. 1, pp. 80–93, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Kajbaf and J.-D. Lalau, “The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis,” BMC Pharmacology and Toxicology, vol. 14, article 22, 2013. View at Publisher · View at Google Scholar · View at Scopus